Rick A. Vreman

Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model

Rick A. Vreman, Alex J. Goodell, Luis A. Rodríguez et al. · BMJ Open · 2017 · 112 citations · Full text

Effects of alcohol hangover on simulated highway driving performance

Joris C. Verster, Adriana C. Bervoets, Suzanne de Klerk et al. · Psychopharmacology · 2014 · 80 citations · Full text

Substance Abuse, Alcohol Hangover, Substance Use +4

Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe

Rick A. Vreman, Huseyin Naci, Wim Goettsch et al. · Clinical Pharmacology & Therapeutics · 2020 · 76 citations · Full text

Clinical Decision-making, United States, Medical Decision Making +19

Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs

Rick A. Vreman, Jacoline C. Bouvy, Lourens T. Bloem et al. · Clinical Pharmacology & Therapeutics · 2018 · 56 citations · Full text

Preclinical Therapeutics, Drug Assessment, Preventive Medicine +17

Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations

Rick A. Vreman, Aukje K. Mantel‐Teeuwisse, Anke M. Hövels et al. · Value in Health · 2020 · 54 citations · Full text